Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JA1Z
|
||||
| Former ID |
DIB015262
|
||||
| Drug Name |
TA-6666
|
||||
| Synonyms |
T-6666; 815541
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 2 | [1] | ||
| Company |
GlaxoSmithKline plc
|
||||
| Target and Pathway | |||||
| Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [2] | |
| KEGG Pathway | Protein digestion and absorption | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020875) | ||||
| REF 2 | Dipeptidyl Peptidase-4 Inhibitors Clinical data and clinical implications. before print March 2, 2007. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.